CD19-Targeting CAR T-Cell Therapy for Antisynthetase Syndrome

被引：2
|
作者：
Lundberg, Ingrid E. [1 ,2 ,3 ]
Galindo-Feria, Angeles S. [1 ,2 ,3 ]
Horuluoglu, Begum [1 ,2 ,3 ]
机构：
[1] Solna Karolinska Inst, Div Rheumatol, Dept Med, Stockholm, Sweden
[2] Karolinska Univ Hosp, Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Gastro Dermatol & Rheumatol, Stockholm, Sweden
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 329卷 / 24期
关键词：
ADULT POLYMYOSITIS;
D O I：
10.1001/jama.2023.7240
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2130 / 2131
页数：2
相关论文
共 50 条
  • [1] CD19-Targeting CAR T Cells forMyositis and Interstitial Lung Disease Associated With Antisynthetase Syndrome
    Pecher, Ann-Christin
    Hensen, Luca
    Klein, Reinhild
    Schairer, Rebekka
    Lutz, Katrin
    Atar, Daniel
    Seitz, Christian
    Stanger, Anna
    Schneider, Janine
    Braun, Christiane
    Schmidt, Marina
    Horger, Marius
    Bornemann, Antje
    Faul, Christoph
    Bethge, Wolfgang
    Henes, Joerg
    Lengerke, Claudia
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (24): : 2154 - 2162
  • [2] CD19-Targeting CAR-T Cell Therapy in CNS Lymphoma
    Siddiqi, Tanya
    Wang, Xiuli
    Palmer, Joycelynne
    Popplewell, Leslie L.
    Nikolaenko, Liana
    Herrera, Alex F.
    Budde, Lihua E.
    Lim, Laura
    Vyas, Vibhuti
    Brown, Christine E.
    Forman, Stephen J.
    BLOOD, 2019, 134
  • [3] Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
    Na Zheng
    Yihao Long
    Zixuan Bai
    Jianing Li
    Hongyu Wang
    Dan-Dan Song
    Hong-Lin Liu
    Jian-Hong Shi
    Shuli Zhao
    Journal of Translational Medicine, 22
  • [4] Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
    Zheng, Na
    Long, Yihao
    Bai, Zixuan
    Li, Jianing
    Wang, Hongyu
    Song, Dan-Dan
    Liu, Hong-Lin
    Shi, Jian-Hong
    Zhao, Shuli
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [5] CD19-Targeting CAR T-Cell Therapy in Transformed Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma: A Descar-T and US Collaborative Study
    Durot, Eric
    Roos-Weil, Damien
    Chauchet, Adrien
    Decroocq, Justine
    Di Blasi, Roberta
    Gastinne, Thomas
    Bensader, Hedi
    Cheminant, Morgane
    Jacquet, Caroline
    Guidez, Stephanie
    Gros, Francois-Xavier
    Bachy, Emmanuel
    Cony-Makhoul, Pascale
    Treon, Steven P.
    Delmer, Alain Jacques
    Reshef, Ran
    Le Gouill, Steven
    Castillo, Jorge J.
    Houot, Roch
    BLOOD, 2023, 142
  • [6] Advances in CD19-targeting CAR-T cell therapies for multiple myeloma
    Steinhardt, Maximilian J.
    Einsele, Hermann
    Waldschmidt, Johannes M.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2025, 25 (01) : 21 - 25
  • [7] CD19-targeting CAR-T cell treatment in patients with diffuse systemic sclerosis
    Avouac, Jerome
    LANCET RHEUMATOLOGY, 2025, 7 (02): : e74 - e75
  • [8] First Analyses of Transcriptomic Changes in the Skin of SSc Patients upon CD19-targeting CAR T Cell Therapy
    Auth, Janina
    Selvaraju, Manoj Kumar
    Mueller, Fabian
    Gupta, Pooja
    Ekici, Arif
    Tur, Carlo
    Raimondo, Maria Gabriella
    Distler, Joerg
    Dees, Clara
    Chenguiti, Sara
    Hagen, Melanie
    Wirsching, Andreas
    Taubmann, Jule
    Kharboutli, Soraya
    Spoerl, Silvia
    Aigner, Michael
    Kretschmann, Sascha
    Vasova, Ingrid
    MAckensen, Andreas
    Schett, Georg
    Bergmann, Christina
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1644 - 1646
  • [9] CD19-targeting CAR T cell immunotherapy outcomes correlate with genomic modification by vector integration
    Nobles, Christopher L.
    Sherrill-Mix, Scott
    Everett, John K.
    Reddy, Shantan
    Fraietta, Joseph A.
    Porter, David L.
    Frey, Noelle
    Gill, Saar I.
    Grupp, Stephan A.
    Maude, Shannon L.
    Siegel, Donald L.
    Levine, Bruce L.
    June, Carl H.
    Lacey, Simon F.
    Melenhorst, J. Joseph
    Bushman, Frederic D.
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (02): : 673 - 685
  • [10] Two CD19-targeting CAR-T therapies progress in clinical trials
    不详
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (08) : 1734 - 1734
12345